These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16225257)

  • 1. [Pathogenesis of primary systemic vasculitides (I): ANCA-positive vasculitides].
    Guilpain P; Chanseaud Y; Tamby MC; Mahr A; Servettaz A; Guillevin L; Mouthon L
    Presse Med; 2005 Aug; 34(14):1013-22. PubMed ID: 16225257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New aspects in ANCA-associated vasculitides].
    Lamprecht P
    Med Klin (Munich); 2004 Sep; 99(9):518-22. PubMed ID: 15372181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides.
    Csernok E
    Autoimmun Rev; 2003 May; 2(3):158-64. PubMed ID: 12848957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antineutrophil cytoplasmic antibodies].
    Sebastiani GD
    Reumatismo; 2009; 61(1):69-76. PubMed ID: 19370191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis.
    Gross WL; Csernok E; Helmchen U
    APMIS; 1995 Feb; 103(2):81-97. PubMed ID: 7748541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
    Kallenberg CG; Heeringa P; Stegeman CA
    Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis.
    Holland M; Takada K; Okumoto T; Takahashi N; Kato K; Adu D; Ben-Smith A; Harper L; Savage CO; Jefferis R
    Clin Exp Immunol; 2002 Jul; 129(1):183-90. PubMed ID: 12100039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
    Reynolds WF; Stegeman CA; Tervaert JW
    Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Kallenberg CG; Rarok A; Stegeman CA; Limburg PC
    Autoimmun Rev; 2002 Feb; 1(1-2):61-6. PubMed ID: 12849060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathways to ANCA production: from differentiation of dendritic cells by proteinase 3 to B lymphocyte maturation in Wegener's granuloma.
    Csernok E; Moosig F; Gross WL
    Clin Rev Allergy Immunol; 2008 Jun; 34(3):300-6. PubMed ID: 18181035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis.
    Malenica B; Rudolf M; Kozmar A
    Acta Dermatovenerol Croat; 2004; 12(4):294-313. PubMed ID: 15588565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenic role of antimyeloperoxidase antibodies].
    Guilpain P; Maldini C; Guillevin L
    Rev Med Interne; 2011 Jul; 32(7):411-5. PubMed ID: 20633964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New insights into the pathogenesis of ANCA-positive vasculitides].
    Guilpain P; Guillevin L; Mouthon L
    Presse Med; 2007 May; 36(5 Pt 2):854-9. PubMed ID: 17350787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A familial case of P-ANCA glomerulonephritis presenting in a father and daughter.
    Hull CM; Couser WG; Knostman JD
    Am J Kidney Dis; 2000 May; 35(5):E23. PubMed ID: 10793052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis.
    Fienberg R; Mark EJ; Goodman M; McCluskey RT; Niles JL
    Hum Pathol; 1993 Feb; 24(2):160-8. PubMed ID: 8381764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.